FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2228075402> ?p ?o ?g. }

• W2228075402 endingPage "2737" @default.
• W2228075402 startingPage "2731" @default.
• W2228075402 abstract "Associations between thromboembolism and malignancy, usually widespread, and between thromboembolism and hormonal and/or chemotherapy have been previously reported. We performed a randomized trial of tamoxifen 30 mg/d for 2 years (T) versus T plus 6 months of intravenous chemotherapy with cyclophosphamide, methotrexate, and fluorouracil (CMF) for postmenopausal women with involved axillary nodes and positive estrogen receptor (ER) or progesterone receptor (PgR) status following primary therapy for breast cancer.We observed one or more thromboembolic events in 48 of 353 women (13.6%) allocated to receive T plus CMF in comparison to five of 352 women (2.6%) randomized to receive T alone (P < .0001). Six women in the T plus CMF arm, but none randomized to receive T alone, suffered two thromboembolic events while an study therapy. There were also significantly more women who developed severe (grade 3 to 5) thromboembolic events in the T plus CMF arm than in the T arm (34 v five; P < .0001). Most thromboembolic events (39 of 54) occurred while women were actually receiving chemotherapy (P < .0001). Thromboembolic complications resulted in more days in hospital and more deaths than any other complication of therapy, including infection, in this trial.Thromboembolism related to the addition of CMF chemotherapy to tamoxifen as adjuvant therapy in this group of women represents a relatively common and serious complication that may outweigh any benefits offered by this additional therapy." @default.
• W2228075402 created "2016-06-24" @default.
• W2228075402 creator A5022450249 @default.
• W2228075402 creator A5024668584 @default.
• W2228075402 creator A5032748645 @default.
• W2228075402 creator A5049907389 @default.
• W2228075402 creator A5062767641 @default.
• W2228075402 creator A5089555383 @default.
• W2228075402 date "1996-10-01" @default.
• W2228075402 modified "2023-10-18" @default.
• W2228075402 title "Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group." @default.
• W2228075402 cites W1583239328 @default.
• W2228075402 cites W1789222663 @default.
• W2228075402 cites W1877444399 @default.
• W2228075402 cites W1929485622 @default.
• W2228075402 cites W1965624945 @default.
• W2228075402 cites W1966623655 @default.
• W2228075402 cites W1967832446 @default.
• W2228075402 cites W1971495991 @default.
• W2228075402 cites W2006677868 @default.
• W2228075402 cites W2010410354 @default.
• W2228075402 cites W2012252399 @default.
• W2228075402 cites W2034826298 @default.
• W2228075402 cites W2037367216 @default.
• W2228075402 cites W2087377401 @default.
• W2228075402 cites W2090507834 @default.
• W2228075402 cites W2094360632 @default.
• W2228075402 cites W2099127305 @default.
• W2228075402 cites W2100184560 @default.
• W2228075402 cites W2105076124 @default.
• W2228075402 cites W2128069055 @default.
• W2228075402 cites W2150290224 @default.
• W2228075402 cites W2225669013 @default.
• W2228075402 cites W2272183589 @default.
• W2228075402 cites W2328710175 @default.
• W2228075402 cites W2413613545 @default.
• W2228075402 cites W96112255 @default.
• W2228075402 doi "https://doi.org/10.1200/jco.1996.14.10.2731" @default.
• W2228075402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8874334" @default.
• W2228075402 hasPublicationYear "1996" @default.
• W2228075402 type Work @default.
• W2228075402 sameAs 2228075402 @default.
• W2228075402 citedByCount "251" @default.
• W2228075402 countsByYear W22280754022012 @default.
• W2228075402 countsByYear W22280754022013 @default.
• W2228075402 countsByYear W22280754022014 @default.
• W2228075402 countsByYear W22280754022015 @default.
• W2228075402 countsByYear W22280754022016 @default.
• W2228075402 countsByYear W22280754022017 @default.
• W2228075402 countsByYear W22280754022018 @default.
• W2228075402 countsByYear W22280754022019 @default.
• W2228075402 countsByYear W22280754022020 @default.
• W2228075402 countsByYear W22280754022021 @default.
• W2228075402 countsByYear W22280754022022 @default.
• W2228075402 countsByYear W22280754022023 @default.
• W2228075402 crossrefType "journal-article" @default.
• W2228075402 hasAuthorship W2228075402A5022450249 @default.
• W2228075402 hasAuthorship W2228075402A5024668584 @default.
• W2228075402 hasAuthorship W2228075402A5032748645 @default.
• W2228075402 hasAuthorship W2228075402A5049907389 @default.
• W2228075402 hasAuthorship W2228075402A5062767641 @default.
• W2228075402 hasAuthorship W2228075402A5089555383 @default.
• W2228075402 hasConcept C121608353 @default.
• W2228075402 hasConcept C126322002 @default.
• W2228075402 hasConcept C141071460 @default.
• W2228075402 hasConcept C143998085 @default.
• W2228075402 hasConcept C168563851 @default.
• W2228075402 hasConcept C2776067312 @default.
• W2228075402 hasConcept C2776694085 @default.
• W2228075402 hasConcept C2776755627 @default.
• W2228075402 hasConcept C2777176818 @default.
• W2228075402 hasConcept C2777982462 @default.
• W2228075402 hasConcept C2778311097 @default.
• W2228075402 hasConcept C530470458 @default.
• W2228075402 hasConcept C71924100 @default.
• W2228075402 hasConceptScore W2228075402C121608353 @default.
• W2228075402 hasConceptScore W2228075402C126322002 @default.
• W2228075402 hasConceptScore W2228075402C141071460 @default.
• W2228075402 hasConceptScore W2228075402C143998085 @default.
• W2228075402 hasConceptScore W2228075402C168563851 @default.
• W2228075402 hasConceptScore W2228075402C2776067312 @default.
• W2228075402 hasConceptScore W2228075402C2776694085 @default.
• W2228075402 hasConceptScore W2228075402C2776755627 @default.
• W2228075402 hasConceptScore W2228075402C2777176818 @default.
• W2228075402 hasConceptScore W2228075402C2777982462 @default.
• W2228075402 hasConceptScore W2228075402C2778311097 @default.
• W2228075402 hasConceptScore W2228075402C530470458 @default.
• W2228075402 hasConceptScore W2228075402C71924100 @default.
• W2228075402 hasIssue "10" @default.
• W2228075402 hasLocation W22280754021 @default.
• W2228075402 hasLocation W22280754022 @default.
• W2228075402 hasOpenAccess W2228075402 @default.
• W2228075402 hasPrimaryLocation W22280754021 @default.
• W2228075402 hasRelatedWork W1771722205 @default.
• W2228075402 hasRelatedWork W2009869235 @default.
• W2228075402 hasRelatedWork W2016451117 @default.
• W2228075402 hasRelatedWork W2049746519 @default.
• W2228075402 hasRelatedWork W2099666259 @default.

• next